Devices › Device types
FDA product code DRA · class 2 · Cardiovascular
Catheter, steerable: medical device reports filed with FDA
13,946 reports carry this product code, 1992–2026; 20 brands with a page.
- 13,946
- reports with this product code
- 0.1% of all MAUDE reports
- 2,648
- reports, 12 months to August 2026
- 3,908 in the 12 months before
- 61.9%
- classified as malfunction
- 62.3% across all reports
- 1.8%
- classified as death, as reported
- 0.9% across all reports
Product code DRA is FDA's classification for "Catheter, steerable" (cardiovascular panel), a class 2 device. 13,946 medical device reports carry this product code, 0.1% of the MAUDE database, from February 1992 to August 2026.
2,648 reports arrived in the 12 months to August 2026, down 32% from 3,908 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (61.9%), injury (36.2%) and death (1.8%). 20 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| FARADRIVE Steerable Sheath Clear | 4,151 | 1,559 | 0.5% | 89.2% |
| FlexCath Advance Steerable Sheath | 2,939 | 58 | 3.5% | 45.4% |
| Mitraclip System Steerable Guide Catheter | 1,527 | 16 | 3% | 43% |
| G4 Steerable Guiding Catheter | 896 | 0 | 1.6% | 43.3% |
| FlexCath Contour Steerable Sheath | 871 | 399 | 1.5% | 62% |
| Faradrive | 792 | 192 | 0.9% | 78.2% |
| Mitraclip | 753 | 1,161 | 2% | 42.5% |
| Polarsheath | 378 | 12 | 1.2% | 68.9% |
| Flexcath Steerable Sheath | 364 | 0 | 0.3% | 67.9% |
| Steerable Guide Catheter | 335 | 33 | 1.2% | 38.1% |
| G4 Steerable Guiding Catheter Ce | 262 | 2 | 1.1% | 51.5% |
| FARADRIVE Steerable Sheath | 192 | 102 | 4.2% | 33.3% |
| Mitraclip G4 Steerable Guide Catheter Mdr | 191 | 0 | 1.6% | 45% |
| Heartlight | 17 | 0 | 1% | 6.8% |
| Artisan? | 11 | 127 | 0.6% | 13% |
| Arctic Front Advance Cardiac Cryoablation Catheter | 8 | 46 | 2.6% | 53.8% |
| Farawave | 3 | 1,409 | 3.6% | 53.6% |
| FARAWAVE Nav | 1 | 404 | 3.2% | 49.5% |
| MITRACLIP SYSTEM Clip Delivery System | 1 | 299 | 14.9% | 24.8% |
| Polarxfit | 1 | 17 | 1.7% | 65.1% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Boston Scientific | 3,722 | 26.7% |
| Medtronic Cryocath | 3,331 | 23.9% |
| Abbott Vascular | 1,159 | 8.3% |
| Av-Temecula-Ct | 1,138 | 8.2% |
| Abbott Medical | 1,025 | 7.3% |
| Farapulse | 885 | 6.3% |
| Medtronic Ireland | 847 | 6.1% |
| Abbott Vascular-Cardiac Therapies | 11 | 0.1% |
| St Jude Medical | 7 | 0.1% |
| Greatbatch Medical | 3 | 0% |
| Medtronic Perfusion Systems | 2 | 0% |
| Biosense Webster | 1 | 0% |
| Medtronic | 1 | 0% |
| Medtronic Mexico S De R L De Cv | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Air/gas in device | 3,307 | 23.7% |
| Leak/splashthe device leaked | 2,325 | 16.7% |
| Material twisted/bent | 657 | 4.7% |
| Fluid/blood leak | 604 | 4.3% |
| Gas/air leak | 597 | 4.3% |
| Material integrity problema problem with the device material | 520 | 3.7% |
| Device contamination with body fluid | 417 | 3% |
| Air leak | 404 | 2.9% |
| Nonstandard device | 389 | 2.8% |
| Difficult to advance | 250 | 1.8% |
| Breakthe device broke | 246 | 1.8% |
| Deformation due to compressive stress | 202 | 1.4% |
| Difficult to insertthe device was hard to insert | 182 | 1.3% |
| Difficult to removethe device was hard to remove | 152 | 1.1% |
| Suction problem | 148 | 1.1% |
| Failure to advance | 147 | 1.1% |
| Insufficient device problem information | 143 | 1% |
| Improper or incorrect procedure or method | 121 | 0.9% |
| Mechanical problema mechanical problem | 120 | 0.9% |
| Positioning failure | 120 | 0.9% |
Questions about catheter, steerable reports
What is product code DRA?
FDA's classification code for "Catheter, steerable", class 2, reviewed by the cardiovascular panel. Every device report carries the product code of the device involved.
How many reports carry this code?
13,946 reports through August 2026, 2,648 of them in the latest 12 months.
Which brands appear most often?
FARADRIVE Steerable Sheath Clear (4,151), FlexCath Advance Steerable Sheath (2,939), Mitraclip System Steerable Guide Catheter (1,527), G4 Steerable Guiding Catheter (896) and FlexCath Contour Steerable Sheath (871). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.